Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
2.04M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
55.5K
-
Shares change
-
+24.8K
-
Total reported value, excl. options
-
$205K
-
Value change
-
+$90.4K
-
Number of buys
-
5
-
Number of sells
-
-4
-
Price
-
$3.69
Significant Holders of NeuroMetrix, Inc. - Common Stock, $0.0001 par value per share (NURO) as of Q2 2024
15 filings reported holding NURO - NeuroMetrix, Inc. - Common Stock, $0.0001 par value per share as of Q2 2024.
NeuroMetrix, Inc. - Common Stock, $0.0001 par value per share (NURO) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.5K shares
of 2.04M outstanding shares and own 2.72% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (15.1K shares), GEODE CAPITAL MANAGEMENT, LLC (13.7K shares), CITADEL ADVISORS LLC (12.2K shares), OSAIC HOLDINGS, INC. (6.69K shares), BlackRock Inc. (5.01K shares), Tower Research Capital LLC (TRC) (1.71K shares), Accent Capital Management, LLC (625 shares), TUCKER ASSET MANAGEMENT LLC (402 shares), Stephens Consulting, LLC (62 shares), and BANK OF AMERICA CORP /DE/ (16 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.